Chimerix Inc (CMRX)

3.47 -0.19 (-5.19%) USD  |  NASDAQ  |  Jan 08, 12:35
More

Chimerix Research and Development Expense (Annual): 68.79M for Dec. 31, 2023

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CMRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Cumberland Pharmaceuticals Inc 5.834M
Abbott Laboratories 2.741B
Emergent BioSolutions Inc 111.40M
Tonix Pharmaceuticals Holding Corp 86.66M
Geovax Labs Inc 20.72M